BRITISH COLUMBIA, Canada--(BUSINESS WIRE)--InNexus Biotechnology Inc. (OTCBB:IXSBF) (TSX VENTURE:IXS), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL™) technology, is pleased to announce that Jeff Morhet, Chairman and CEO, will be a keynote speaker at the Toronto Stock Exchange Group Roadshow, being held at the Arizona Biltmore Resort & Spa in Scottsdale, Arizona on Tuesday, October 2, 2007. Mr. Morhet is scheduled to present at 12:00 PM PT in the Grand Ballroom. The presentation will include an overview of the Company’s business strategy and future milestones. InNexus’ Chief Financial Officer, Wade Brooksby, will also be in attendance.
